Zoetis, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses

LOS ANGELES, April 12, 2024 (GLOBE NEWSWIRE) -- ​The Portnoy Law Firm advises Zoetis, Inc. (“Zoetis”) (NYSE: ZTS) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Zoetis investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: info@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Shares of Zoetis dropped sharply in trading on April 12 following a Wall Street Journal article describing how Health regulators in the US and Europe are conducting reviews of the firm’s drugs Librela and Solensia after having received “thousands of reports of side effects.”

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY and TX Bar

Attorney Advertising